139 related articles for article (PubMed ID: 30902708)
21. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
Kruse K; Gerwin E; Eichel A; Shah-Hosseini K; Mösges R
J Allergy Clin Immunol Pract; 2015; 3(3):381-6. PubMed ID: 25609338
[TBL] [Abstract][Full Text] [Related]
22. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.
Golebski K; Layhadi JA; Sahiner U; Steveling-Klein EH; Lenormand MM; Li RCY; Bal SM; Heesters BA; Vilà-Nadal G; Hunewald O; Montamat G; He FQ; Ollert M; Fedina O; Lao-Araya M; Vijverberg SJH; Maitland-van der Zee AH; van Drunen CM; Fokkens WJ; Durham SR; Spits H; Shamji MH
Immunity; 2021 Feb; 54(2):291-307.e7. PubMed ID: 33450188
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
[TBL] [
